{
  "docId": "019de073-9f6d-75d9-b724-0b887fde2468",
  "docSlug": "f957aa564e21bc93d4cc30c084ec8efa",
  "documentTitle": "Aldeyra Therapeutics | Results Presentation Deck | 13 slides",
  "authorId": "aldeyra-therapeutics",
  "authorName": "Aldeyra Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 13,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9f6d-75d9-b724-0b887fde2468/11",
  "deckHref": "/decks/019de073-9f6d-75d9-b724-0b887fde2468",
  "deckJsonHref": "/decks/019de073-9f6d-75d9-b724-0b887fde2468.json",
  "deckAnchorHref": "/decks/019de073-9f6d-75d9-b724-0b887fde2468#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.08,
        "y": 0.48
      },
      "kind": "list",
      "text": "The incidence of punctate keratitis was substantially less than that previously reported (58%)† for intravitreal methotrexate.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c2ae614-7bc4-4dad-b8be-130d3e96556a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.08,
        "y": 0.6
      },
      "kind": "list",
      "text": "ADX-2191 treatment was discontinued in one (1%) patient, due to scheduling difficulty.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4ebe3cf-6060-45ed-8e7d-fd6159235ce6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.08,
        "y": 0.32
      },
      "kind": "list",
      "text": "The most common adverse event associated with ADX-2191 administration was punctate keratitis (n=11, 16%), a well-known side effect of intravitreal methotrexate. Nine events were mild; two were moderate.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3e01ca6-f29d-4744-a1f0-e7fea82d2ecd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.08,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "†Annals of Hematology, 95(4), 593-601, 2016. ADX-2191 (methotrexate injection, USP) for intravitreal administration is an investigational drug candidate.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce259fab-ccc2-45d6-aacd-b27ffdca64f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "ADX-2191 Was Well Tolerated and No Safety Concerns Were Observed",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb52313d-8eca-47c9-b91b-2bb2cee68870",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}